Bristol-Myers Squibb Company

URI: https://gptkb.org/entity/Bristol-Myers_Squibb_Company

GPTKB entity

Statements (88)

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:acquiredBy	gptkb:Celgene
gptkbp:acquisitionYear	2019
gptkbp:CEO	gptkb:Giovanni_Caforio
gptkbp:division	immunology oncology cardiovascular fibrosis
gptkbp:founded	1887
gptkbp:founder	gptkb:John_Ripley_Myers gptkb:William_McLaren_Bristol
gptkbp:headquartersLocation	gptkb:New_York_City
https://www.w3.org/2000/01/rdf-schema#label	Bristol-Myers Squibb Company
gptkbp:industry	pharmaceuticals
gptkbp:listedOn	gptkb:Fortune_500
gptkbp:memberOf	gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkbp:netIncome	$6.33 billion (2023)
gptkbp:notableEmployee	gptkb:Christopher_Boerner gptkb:Giovanni_Caforio gptkb:Chris_Boerner Catherine Owen Adam Lenkowsky Ann Powell David Elkins Estelle Vester-Blokland Nadim Ahmed Rupert Vessey Samit Hirawat
gptkbp:notableProduct	gptkb:Pomalyst gptkb:Revlimid gptkb:Vidaza gptkb:Enfamil gptkb:Eliquis gptkb:Opdivo gptkb:Orencia gptkb:Sprycel gptkb:Yervoy gptkb:Abecma gptkb:Coumadin gptkb:Bufferin gptkb:Inrebic gptkb:Evotaz gptkb:Reyataz gptkb:Reblozyl gptkb:Sea_Breeze gptkb:Excedrin gptkb:Clairol gptkb:Serzone gptkb:Mum gptkb:Breyanzi gptkb:Glucophage gptkb:Nulojix gptkb:Ban gptkb:Vitalis gptkb:Atripla gptkb:Sustiva gptkb:Plavix gptkb:Paraplatin gptkb:Taxol gptkb:Baraclude gptkb:Camzyos Keri Pravachol Capoten Zeposia Daklinza BuSpar Datril Empliciti Nuprin Onureg Sunvepra
gptkbp:numberOfEmployees	over 32,000
gptkbp:parentCompany	none
gptkbp:products	gptkb:Revlimid gptkb:Eliquis gptkb:Opdivo gptkb:Orencia gptkb:Sprycel gptkb:Yervoy
gptkbp:revenue	$46.16 billion (2023)
gptkbp:servesArea	worldwide
gptkbp:stockExchange	gptkb:NYSE
gptkbp:stockSymbol	gptkb:BMY
gptkbp:type	gptkb:public_company
gptkbp:website	https://www.bms.com/
gptkbp:bfsParent	gptkb:S&P_500_Top_50
gptkbp:bfsLayer	8